Recent Price Movement and Short-Term Performance
As of the latest available data, Genomic Valley Biotech Ltd’s shares have declined by ₹0.85, or 3.22%, signalling a negative trading session. This drop is consistent with the stock’s broader short-term trend, as it has lost 8.86% over the past week and the past month. These declines are considerably sharper than the benchmark Sensex, which fell by only 1.55% in the last week and gained 5.06% over the last month. The stock’s underperformance relative to the broader market in recent weeks suggests investor caution or profit-taking pressures weighing on the share price.
Year-to-Date and Longer-Term Context
Despite the recent weakness, Genomic Valley Biotech Ltd has managed a modest gain of 3.28% year...
Read full news article





